Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis.
D'Amato M, Menzella F, Altieri E, Bargagli E, Bracciale P, Brussino L, Caiaffa MF, Canonica GW, Caruso C, Centanni S, De Michele F, Di Marco F, Pastorello EA, Pelaia G, Rogliani P, Romagnoli M, Schino P, Senna G, Vultaggio A, Ori A, Simoni L, Boarino S, Vitiello G, Aliani M, Del Giacco S. D'Amato M, et al. Among authors: aliani m. Front Allergy. 2022 May 18;3:881218. doi: 10.3389/falgy.2022.881218. eCollection 2022. Front Allergy. 2022. PMID: 35769575 Free PMC article.
Monitoring of atmospheric conditions and forecast of olive pollen season.
Macchia L, Aliani M, Caiaffa MF, Carbonara AM, Gatti E, Iacobelli A, Strada S, Casella G, Tursi A. Macchia L, et al. Among authors: aliani m. Experientia Suppl. 1987;51:95-9. doi: 10.1007/978-3-0348-7491-5_17. Experientia Suppl. 1987. PMID: 2958358 No abstract available.
Association between exhaled nitric oxide and nasal polyposis in severe asthma.
Maniscalco M, Calabrese C, D'Amato M, Guida P, Molino A, Aliani M, De Tullio R, Foschino Barbaro M, Ricciardolo FLM, Carpagnano GE. Maniscalco M, et al. Among authors: aliani m. Respir Med. 2019 Jun;152:20-24. doi: 10.1016/j.rmed.2019.04.017. Epub 2019 Apr 25. Respir Med. 2019. PMID: 31128605 Free article.
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
Menzella F, Bargagli E, Aliani M, Bracciale P, Brussino L, Caiaffa MF, Caruso C, Centanni S, D'Amato M, Del Giacco S, De Michele F, Di Marco F, Pastorello EA, Pelaia G, Rogliani P, Romagnoli M, Schino P, Senna G, Vultaggio A, Simoni L, Ori A, Boarino S, Vitiello G, Altieri E, Canonica GW. Menzella F, et al. Among authors: aliani m. Respir Res. 2022 Feb 19;23(1):36. doi: 10.1186/s12931-022-01952-8. Respir Res. 2022. PMID: 35183167 Free PMC article.
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis.
Caruso C, Cameli P, Altieri E, Aliani M, Bracciale P, Brussino L, Caiaffa MF, Canonica GW, Centanni S, D'Amato M, Del Giacco S, De Michele F, Pastorello EA, Pelaia G, Rogliani P, Romagnoli M, Schino P, Caminati M, Vultaggio A, Zullo A, Rizzoli S, Boarino S, Vitiello G, Menzella F, Di Marco F. Caruso C, et al. Among authors: aliani m. Front Med (Lausanne). 2022 Sep 2;9:950883. doi: 10.3389/fmed.2022.950883. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36117962 Free PMC article.
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study.
Senna G, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Cameli P, Canonica GW, Caruso C, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, Rizzoli S, Zullo A, Boarino S, Palmisano M, Rossi A, Vitiello G, Centanni S. Senna G, et al. Among authors: aliani m. J Asthma Allergy. 2022 Nov 10;15:1593-1604. doi: 10.2147/JAA.S383012. eCollection 2022. J Asthma Allergy. 2022. PMID: 36387835 Free PMC article.
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Vultaggio A, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Senna G, Benci M, Boarino S, Schroeder JW. Vultaggio A, et al. Among authors: aliani m. Respir Res. 2023 May 20;24(1):135. doi: 10.1186/s12931-023-02439-w. Respir Res. 2023. PMID: 37210543 Free PMC article.
Severe asthma: follow-up after one year from the Italian Registry on Severe Asthma (IRSA).
Bilò MB, Martini M, Antonicelli L, Aliani M, Carone M, Cecchi L, de Michele F, Polese G, Vaghi A, Musarra A, Micheletto C; IRSA Follow-up Study Group. Bilò MB, et al. Among authors: aliani m. Eur Ann Allergy Clin Immunol. 2023 Sep;55(5):199-211. doi: 10.23822/EurAnnACI.1764-1489.304. Epub 2023 Jul 17. Eur Ann Allergy Clin Immunol. 2023. PMID: 37462932 Free article.
118 results